Potassium Orotate, tablets 500 mg, №10

Pharmacological Properties
Potassium Orotate has a general stimulating effect on metabolic processes, participating in protein and carbohydrate metabolism. The main structural element of potassium orotate is orotic acid. Orotic acid ensures the synthesis of pyrimidine bases (uracil, thymine, cytosine) during nucleic acid synthesis, which are essential for protein molecule synthesis. Orotic acid’s role in carbohydrate metabolism lies in its normalizing effect on galactose metabolism. Potassium orotate, as an anabolic agent, is used to restore protein metabolism disturbances and stimulate metabolic processes.

Special Warnings and Precautions
Potassium Orotate should not be used for potassium replacement therapy.
Potassium Orotate should not be taken with food due to potential interactions with food components. The drug contains lactose, so it is contraindicated in patients with rare hereditary conditions such as galactose intolerance, lactase deficiency, and glucose-galactose malabsorption syndrome.

Dosage and Administration
Potassium Orotate should be taken orally 1 hour before or 4 hours after meals. Swallow the tablets whole with 150-200 ml of water. Adults: 250-500 mg 2-3 times daily. The maximum daily dose is 500-1500 mg. In some cases, to increase therapeutic efficacy, the daily dose for adults can be increased to 3000 mg. Treatment course: 3-5 weeks. If necessary, repeat the course after 1 month. Children (5 years and older): 10-20 mg per kg of body weight daily, divided into 2-3 doses.

Pediatric Use
Not recommended for children under 5 years of age.